PETNET Avid Announcement
Read more here
News
QR Pharma Receives US Patent 7,625,942 to Treat Down Syndrome
Read more here
QR Pharma Initiates Clinical Trial for Cognitively Impaired Patients
Read more here
PETNET Avid Announcement
Read more here
QR Pharma Receives US Patent 7,625,942 to Treat Down Syndrome
Read more here
QR Pharma Initiates Clinical Trial for Cognitively Impaired Patients
Read more here